Our data identified FOXC1 derepression as a hallmark of CLL-derived RS, likely associated with the blockade of B cell development and proliferation due to NF-KB signaling unleashing. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.